Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Xaira, Anthos, CureVac & more—Chutes & Ladders
Ousted former Stanford president to lead new billion-dollar biotech. Fresh off BMS buy, Karuna’s ex-CEO to helm Anthos. CureVac names new CBO.
Max Bayer
,
Gabrielle Masson
,
Andrea Park
Apr 26, 2024 8:30am
Sponsored
Cloud-Based Technology Supports Complex Supply Chains
Apr 22, 2024 8:00am
Former FDA leader Woodcock inspires Biotech Sisterhood summit
Apr 24, 2024 9:23am
Regeneron signs Mammoth gene editing deal worth $100M upfront
Apr 25, 2024 8:49am
Pfizer collab with CeMM leads to new drug discovery AI models
Apr 26, 2024 6:30am
Baker Lab AI makes strides in drug-like peptides
Apr 25, 2024 2:00pm
Medtech News
Boston Scientific sees 70% EP growth after Farapulse launch
Apr 25, 2024 10:00am
Risklick debuts new AI software for clinical trial protocols
Apr 25, 2024 7:25am
Parexel strikes deal with Palantir for clinical trial AI
Apr 25, 2024 6:59am
Exo brings AI heart, lung apps to its hand-held ultrasound probe
Apr 24, 2024 9:10am
See More Medtech News